Biogen Inc. buy Needham & Company LLC
Start price
26.10.23
/
50%
€229.60
Target price
26.10.24
€289.60
Performance (%)
-26.20%
End price
27.10.24
€169.45
Summary
This prediction ended on 27.10.24 with a price of €169.45. The prediction for Biogen Inc. disappointed with a performance of -26.20%. Needham___Company_LL has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 8.456% | 8.456% | 76.007% |
| iShares Core DAX® | -1,36 % | -2,16 % | 2,08 % |
| iShares Nasdaq 100 | -3,70 % | -1,16 % | 32,60 % |
| iShares Nikkei 225® | -2,51 % | 7,93 % | 58,27 % |
| iShares S&P 500 | -1,66 % | -0,70 % | 22,96 % |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $305.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten